Lupin moves court fearing tax on pre-GST stock

​Lupin, like many other pharma companies, is worried that some of the stock lying in its godowns could face double taxation due to goods and services tax (GST) regulations.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news